Kanabo Group Plc (LON:KNB)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.2200
0.00 (0.00%)
At close: May 19, 2026
Market Cap1.39M -86.8%
Revenue (ttm)1.14M +40.2%
Net Income-8.18M
EPS-0.01
Shares Out632.43M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,421
Average Volume590,510
Open0.2200
Previous Closen/a
Day's Range0.2200 - 0.2200
52-Week Range0.2200 - 0.2200
Beta2.30
RSI26.06
Earnings Daten/a

About Kanabo Group

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well... [Read more]

Sector Healthcare
Founded 2016
Employees 20
Stock Exchange London Stock Exchange
Ticker Symbol KNB
Full Company Profile

Financial Performance

In 2023, Kanabo Group's revenue was 895,000, an increase of 48.42% compared to the previous year's 603,000. Losses were -7.99 million, 16.3% more than in 2022.

Financial Statements